Document 0367
 DOCN  M9460367
 TI    beta-Carotene in HIV infection.
 DT    9404
 AU    Coodley GO; Nelson HD; Loveless MO; Folk C; Division of Internal
       Medicine, Oregon Health Sciences University,; Portland 97201-3098.
 SO    Ann N Y Acad Sci. 1993 Dec 31;691:277-8. Unique Identifier : AIDSLINE
       MED/94175455
 DE    Adjuvants, Immunologic/THERAPEUTIC USE  B-Lymphocytes/DRUG
       EFFECTS/IMMUNOLOGY  Carotene/*THERAPEUTIC USE  Comparative Study
       CD4-CD8 Ratio/DRUG EFFECTS  Human  HIV
       Seropositivity/*IMMUNOLOGY/*THERAPY  Lymphocytes/DRUG
       EFFECTS/*IMMUNOLOGY  Support, Non-U.S. Gov't  Time Factors  CLINICAL
       TRIAL  JOURNAL ARTICLE  RANDOMIZED CONTROLLED TRIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).